Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

37 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma.
Gjertsen MK, Buanes T, Rosseland AR, Bakka A, Gladhaug I, Søreide O, Eriksen JA, Møller M, Baksaas I, Lothe RA, Saeterdal I, Gaudernack G. Gjertsen MK, et al. Among authors: saeterdal i. Int J Cancer. 2001 May 1;92(3):441-50. doi: 10.1002/ijc.1205. Int J Cancer. 2001. PMID: 11291084 Free article. Clinical Trial.
Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation.
Gjertsen MK, Bjorheim J, Saeterdal I, Myklebust J, Gaudernack G. Gjertsen MK, et al. Among authors: saeterdal i. Int J Cancer. 1997 Sep 4;72(5):784-90. doi: 10.1002/(sici)1097-0215(19970904)72:5<784::aid-ijc14>3.0.co;2-9. Int J Cancer. 1997. PMID: 9311595 Free article.
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study.
Gjertsen MK, Bakka A, Breivik J, Saeterdal I, Gedde-Dahl T 3rd, Stokke KT, Sølheim BG, Egge TS, Søreide O, Thorsby E, Gaudernack G. Gjertsen MK, et al. Among authors: saeterdal i. Int J Cancer. 1996 Feb 8;65(4):450-3. doi: 10.1002/(SICI)1097-0215(19960208)65:4<450::AID-IJC10>3.0.CO;2-E. Int J Cancer. 1996. PMID: 8621226 Free article. Clinical Trial.
37 results